Kutatási jelek – Signal Engine

• Combinations Targeting EGFR and KRAS G12C May Advance NSCLC Treatment — NSCLC
• Diffuse Large B-Cell Lymphoma - PMC — Diffuse large B-cell lymphoma
• The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs — Thyroid cancer
• Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study — NSCLC
• A spatial immune scoring system based on the tumor microenvironment features improves prognostic stratification in lung adenocarcinoma — NSCLC
• ADC – ANTIBODY-DRUG CONJUGATES IN ONCOLOGY — Breast cancer
• Dr. Joseph Mikhael — Multiple myeloma
• A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma. — Renal cell carcinoma
• MSK Research Highlights, September 14, 2026 — Colorectal cancer
• A Diagnostic Challenge: Retroperitoneal Extraskeletal Ewing Sarcoma with Subaortic Growth and Partial Aortic Encasement Presenting with Nephrolithiasis-Like Symptoms in a Middle-Aged South Asian Male — Ewing sarcoma
• Anal cancer: research and therapeutic landscape — Anal squamous cell carcinoma
• Ropeginterferon alfa‑2b‑njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single‑arm, multicentre study (EXCEED‑ET) — Acute myeloid leukemia
• Clinical Trials — Endometrial cancer
• Natural products targeting the molecular pathology of salivary gland mucoepidermoid carcinoma: A systematic review of In vitro studies — Head and neck squamous cell carcinoma
• Preclinical trial supports dual inhibition of BCL2 and Aurora kinase A for MYCN-amplified high-risk neuroblastoma — Neuroblastoma
• Postoperative Care and Management in Pediatric Hematology‑Oncology Patients — Hepatocellular carcinoma
• Risk factors and cytology performance for high-grade anal intraepithelial neoplasia in young adults: a cohort study. — Anal squamous cell carcinoma
• Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma — Nasopharyngeal carcinoma
• TROP2 Expression in Bladder Transurethral Resection Specimens: Correlation With Histological Grade and Survival — Bladder cancer
• Cancer treatment alters mutant selection in normal esophagus — Esophageal cancer